Circadian plasma leptin levels in patients with anorexia nervosa: relation to insulin and cortisol. 1998

S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
Clinic of Psychotherapy and Psychosomatics, University of Essen, Germany. stephan.herpertz@uni-essen.de

In anorexia nervosa, underweight results from a loss of body mass due to a restricted energy intake. Circulating leptin levels have been shown to be low in the acute stage of the disorder. We studied diurnal secretion characteristics of leptin, insulin and cortisol in a study group of anorectic patients prior to refeeding, a second study group of anorectic patients after initiation of refeeding and study groups of healthy underweight and normal-weight controls. Spontaneous secretion of leptin, insulin and cortisol was measured by drawing blood samples every 2 h for 24 h. The temporal relationships between the diurnal secretion patterns of the three hormones were assessed by cross-correlation analysis in every study group. Plasma levels of leptin and cortisol were secreted with a specific circadian rhythmicity and displayed an intricate temporal relationship in anorectic patients. Semistarvation in the non-refed patients was associated with (1) exceedingly low plasma leptin levels, (2) a qualitative alteration in the circadian rhythm of leptin and cortisol levels and (3) an alteration in the temporal coupling between cortisol and leptin. In contrast, in the patients who had gained weight, leptin levels were higher; furthermore, the diurnal pattern of leptin and the temporal relationship between leptin and cortisol were similar to controls. Increments in insulin secretion preceded those of leptin by 4-6 h in both anorectic patients and in controls. Leptin levels increased 4 h prior to those of cortisol in controls and in refed patients, whereas in the non-refed patients cortisol increased prior to leptin. Thus, anorexia nervosa leads to pronounced, albeit reversible changes in the secretion dynamics of leptin and cortisol.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000856 Anorexia Nervosa An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994) Anorexia Nervosas,Nervosa, Anorexia,Nervosas, Anorexia

Related Publications

S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
March 2024, Hormones (Athens, Greece),
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
June 1997, Eating and weight disorders : EWD,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
August 2002, Endocrine research,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
October 2000, Casopis lekaru ceskych,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
June 2000, Revista espanola de medicina nuclear,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
June 2004, Journal of endocrinological investigation,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
July 2003, The International journal of eating disorders,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
November 1999, The International journal of eating disorders,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
November 1996, The Journal of clinical endocrinology and metabolism,
S Herpertz, and R Wagner, and N Albers, and W F Blum, and B Pelz, and M Langkafel, and W Köpp, and A Henning, and C Oberste-Berghaus, and K Mann, and W Senf, and J Hebebrand
April 2007, Metabolism: clinical and experimental,
Copied contents to your clipboard!